Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

Completed · Phase 2

Conditions studied: Cocaine Dependence

In brief

We are testing to see if Galantamine, a learning enhancing medication, will help methadone maintained cocaine abusers with their learning and memory specific to CBT using an innovative CBT computer program.

Key facts

Study ID

NCT00809835

Run by

Yale University

People needed

120

Starts

2007-12-01

Expected to finish

2015-01-01

Last updated by the study team

2019-01-30

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females between ages of 18 and 50
• Enrolled in RNP methadone program and stable on methadone for at least 3 weeks
• Current cocaine abuse or dependence according to DSM-IV criteria
• No current medical problems and normal ECG
• If female, not currently pregnant or breast feeding and using reliable birth control
• Fluent in English and have at least a 6th grade reading level
• Can commit to 12 weeks of treatment and are willing to be randomized

You may not qualify if…

• Current major psychiatric illness including mood, psychotic or anxiety disorder
• History of major medical illnesses including asthma, chronic obstructive lung disease, gastrointestinal ulcer, hepatic or renal impairment, cardiac rhythm disturbances
• Use of medications including beta blockers and NASAIDs
• Known allergy to Galantamine

Where it is running

• Kinsella Treatment Center (KTC) — Bridgeport, Connecticut, United States
• Regional Network of Programs — Stratford, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.